Steps Towards Osteoarthritis Prevention: A Pilot Study

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Optimal knee joint loading, which refers to the forces acting on the knee caused by daily activities such as daily steps, plays an essential role in maintaining knee articular cartilage health and reducing the risk of osteoarthritis (OA). After anterior cruciate ligament reconstruction (ACLR), individuals take fewer daily steps as compared to uninjured controls resulting in insufficient knee joint loading to joint tissues, but it is unclear how changes in daily steps impact knee joint cartilage health in OA development. Therefore, the overall single arm, longitudinal pre-test post-test study objective is to determine the mechanistic links between knee joint loading as measured by daily steps and comprehensive magnetic resonance imaging (MRI) measures of knee joint cartilage health post-ACLR. The central hypothesis is that individuals post-ACLR who take low daily steps will demonstrate deconditioned, less resilient cartilage characterized by poor tibiofemoral cartilage composition and greater cartilage strain.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Maximum Age: 40
Healthy Volunteers: f
View:

• Provision of signed and dated informed consent form

• For children, signed and dated informed assent by child and parental permission form by parent/guardian to participate in the study

• Underwent an anterior cruciate ligament reconstruction (ACLR) between 6-60 months prior to enrollment

• Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study

• Completed all other formal physical therapy and therapeutic exercise regimens, and will not be engaging in any other formal therapy for their ACLR during the study

• Physician clearance for unrestricted activity

• Owning a smartphone

• Demonstrate \< 7,000 steps per day during the screening phase of aim 2 as assessed using the Actigraph Link monitor

Locations
United States
Georgia
University of Georgia
RECRUITING
Athens
Contact Information
Primary
Caroline Lisee, PhD
caroline.lisee@uga.edu
706-542-7137
Time Frame
Start Date: 2024-09-23
Estimated Completion Date: 2028-01-30
Participants
Target number of participants: 56
Treatments
Experimental: Interventional Group
Participants who meet study criteria and are enrolled in adaptive daily step promotion intervention
Related Therapeutic Areas
Sponsors
Leads: University of Georgia
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

This content was sourced from clinicaltrials.gov